SoftBank Group (9984) Q1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2025 earnings summary
2 Feb, 2026Executive summary
Reported a net loss of ¥174.3 billion for FY2024Q1, despite an investment gain of ¥559.7 billion, reflecting improved performance compared to the prior year.
Net Asset Value (NAV) reached a record high of ¥35.3 trillion as of June 30, 2024.
Arm's performance exceeded analyst expectations, posting record revenue and 65% year-on-year operating income growth.
Strategic focus on AI and Artificial Super Intelligence (ASI) with investments in AI chips, data centers, and robotics.
Maintained robust financial stability, low loan-to-value ratio, and ample cash reserves to support further AI investments.
Financial highlights
Net sales increased to ¥1,701.7 billion, up ¥144.2 billion or 9.3% year-over-year.
Investment gain of ¥559.7 billion, a turnaround from a ¥699.0 billion loss in the prior year quarter.
Income before income tax was ¥225.7 billion, up ¥401.9 billion year-over-year.
Net loss attributable to owners improved to ¥174.3 billion from ¥477.6 billion loss a year ago.
Cash and cash equivalents stood at ¥5,498.9 billion.
Outlook and guidance
No consolidated earnings or investment guidance provided due to market volatility and unpredictability.
Arm forecasts FY2024Q2 revenue of $780–830 million and full-year revenue of $3.8–4.1 billion.
Arm expects FY2024Q2 non-GAAP EPS of $0.23–$0.27 and full-year EPS of $1.45–$1.65.
Continues to prioritize NAV as the key performance indicator for investors.
Latest events from SoftBank Group
- Net income soared 398.7% on investment gains and strategic AI expansion, led by OpenAI.9984
Q3 202612 Feb 2026 - A $3B joint venture launches to deploy advanced enterprise AI agents in Japan and beyond.9984
Partnership3 Feb 2026 - Net income surged to ¥636.2B on investment gains, Arm growth, and strong financial discipline.9984
Q3 20253 Feb 2026 - First profit in four years, fueled by record investment gains and major AI commitments.9984
Q4 20253 Feb 2026 - AI-powered precision medicine launches in Japan, targeting 1M annual genomic tests and data-driven care.9984
Status Update3 Feb 2026 - Shareholder value hit JPY 34T, Arm led growth, and all proposals passed amid an ASI vision.9984
AGM 20243 Feb 2026 - Net income surged to ¥1,005.3B, led by Vision Fund, T-Mobile, and Arm's record sales.9984
Q2 202515 Jan 2026 - AI-driven demand, advanced chip designs, and ecosystem partnerships fuel strong growth.9984
Investor Update1 Dec 2025 - Net income hit ¥421.8B, with record NAV and share price, led by Arm, Vision Fund, and OpenAI.9984
Q1 202623 Nov 2025